Literature DB >> 15665987

Geographic distribution of hepatitis C virus genotypes in Brazil.

S Campiotto1, J R R Pinho, F J Carrilho, L C Da Silva, F J D Souto, V Spinelli, L M M B Pereira, H S M Coelho, A O Silva, J C Fonseca, H Rosa, C M C Lacet, A P Bernardini.   

Abstract

Brazil is a country of continental dimension with a population of different ethnic backgrounds. Thus, a wide variation in the frequencies of hepatitis C virus (HCV) genotypes is expected to occur. To address this point, 1,688 sequential samples from chronic HCV patients were analyzed. HCV-RNA was amplified by the RT-PCR from blood samples collected from 1995 to 2000 at different laboratories located in different cities from all Brazilian States. Samples were collected in tubes containing a gel separator, centrifuged in the site of collection and sent by express mail in a refrigerated container to Laboratório Bioquímico Jardim Paulista, São Paulo, SP, Brazil. HCV-RNA was extracted from serum and submitted to RT and nested PCR using standard procedures. Nested PCR products were submitted to cycle sequencing reactions without prior purification. Sequences were analyzed for genotype determination and the following frequencies were found: 64.9% (1,095) for genotype 1, 4.6% (78) for genotype 2, 30.2% (510) for genotype 3, 0.2% (3) for genotype 4, and 0.1% (2) for genotype 5. The frequencies of HCV genotypes were statistically different among Brazilian regions (P = 0.00017). In all regions, genotype 1 was the most frequent (51.7 to 74.1%), reaching the highest value in the North; genotype 2 was more prevalent in the Center-West region (11.4%), especially in Mato Grosso State (25.8%), while genotype 3 was more common in the South (43.2%). Genotypes 4 and 5 were rarely found and only in the Southeast, in São Paulo State. The present data indicate the need for careful epidemiological surveys throughout Brazil since knowing the frequency and distribution of the genotypes would provide key information for understanding the spread of HCV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665987     DOI: 10.1590/s0100-879x2005000100007

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  46 in total

Review 1.  Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.

Authors:  Natasha Silva Constancio; Maria Lucia Gomes Ferraz; Carmen Tzanno Branco Martins; Angiolina Campos Kraychete; Paulo Lisboa Bitencourt; Marcelo Mazza do Nascimento
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

Review 2.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy.

Authors:  Jose-Eymard Medeiros-Filho; Isabel-Maria-Vicente-Guedes de Carvalho Mello; Joao-Renato-Rebello Pinho; Avidan-U Neumann; Fernanda de Mello Malta; Luiz-Caetano da Silva; Flair-Jose Carrilho
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

4.  Hierarchical assessment of host factors influencing the spontaneous resolution of hepatitis C infection.

Authors:  Paola Jocelan Scarin Provazzi; Livia Maria Gonçalves Rossi; Bruno Moreira Carneiro; Valeria Chamas Miura; Plinio Cesar Rodrigues Rosa; Lucas Rodrigues de Carvalho; Stephane Tereza Queiroz de Andrade; Roberta Maria Fachini; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Carlos Roberto Valêncio; Paulo Scarpelini Neto; José Antonio Cordeiro; Mauricio Lacerda Nogueira; Paula Rahal
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

5.  Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region.

Authors:  Sueli M Nakatani; Carlos A Santos; Irina N Riediger; Marco A Krieger; Cesar A B Duarte; Marco A Lacerda; Alexander W Biondo; Flair J Carrilho; Flair J Carilho; Suzane K Ono-Nita
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

6.  Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients.

Authors:  Liliana S C Mendes; Marcelo E Nita; Suzane K Ono-Nita; Evandro S Mello; Luiz Caetano da Silva; Venancio A F Alves; Flair J Carrilho
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

7.  Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.

Authors:  M L Alves Pedroso; A B W Boldt; L Pereira-Ferrari; R Steffensen; E Strauss; J C Jensenius; S O Ioshii; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

8.  Hepatitis C virus in blood donors, Brazil.

Authors:  Kátia Luz Torres; Adriana Malheiro; Adriana Tateno; Tatiane Amabile de-Lima; Laura Patricia Viana-Maia; João Paulo Diniz-Pimentel; Márcia Poinho Encarnação-de-Morais; Christiane Santana de-Melo-Usui; Flavia de-Oliveira-Braga; Igor Araújo Ferreira-Silva; Felicien Vasquez; José Eduardo-Levi
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

9.  Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil.

Authors:  Zelma B Costa; Gustavo C Machado; Mariza M Avelino; Clidenor Gomes Filho; Jose V Macedo Filho; Ana L Minuzzi; Marilia D Turchi; Mariane M A Stefani; Wayner Vieira de Souza; Celina Mt Martelli
Journal:  BMC Infect Dis       Date:  2009-07-27       Impact factor: 3.090

10.  Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response.

Authors:  Cíntia Bittar; Ana Carolina G Jardim; Lilian H T Yamasaki; Artur T L de Queiróz; Claudia M A Carareto; João Renato R Pinho; Isabel Maria V G de Carvalho-Mello; Paula Rahal
Journal:  BMC Infect Dis       Date:  2010-02-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.